Close the technology gap and improve patient outcomes , this program provides a review of the latest diabetes technologies, including continuous glucose monitors (CGMs), insulin pumps, automated insulin delivery (AID) systems, and smart insulin pens.

Current evidence-based recommendations for prescribing diabetes medications, including newer pharmacologic classes such as glucagon-like peptide-1 receptor agonists (GLP-1r) and sodium glucose co-transporter-2 inhibitors (SGLTi) medications.